Porton

300363

Current ValuationThe current P/E ratio is -131.75, below the reasonable range, cheaper than 87.73% of the time in the past 5 years, and the industry ranks 215/223, the industry Median 22.04.

-131.75xP/E
Stock price¥23.50Earnings per share¥-0.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.04x
015304560

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.04x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688506SHBIOKIN PHARMACEUTICAL
-79.72x15.13%¥100.77B
000661SZCCHT
-67.08x588.46%¥28.43B
300255SZCSBIO
-49.96x--¥17.54B
688837SHEvopoint
-32.43x--¥14.70B
300363SZPorton
-131.75x105.56%¥12.61B
300436SZCosunter
-58.01x--¥12.17B
300006SZLummy
-87.76x--¥10.49B
002099SZHISOAR
-38.24x--¥8.97B
000908SZCSPC Jingfeng
-343.05x--¥8.76B
688505SHFudan-Zhangjiang
-69.78x--¥7.19B
002737SZSFPM
-49.17x--¥6.92B
600252SHZhongheng Group
-16.28x--¥6.81B
600129SHTAIJI GROUP
-341.17x127.27%¥6.69B
600422SHKPC
-23.00x90.58%¥6.56B
688176SHAsieris
-11.83x1.35%¥6.26B
002424SZGZBL
-47.70x--¥6.17B
603229SHAusun Pharm
-1,332.36x106.25%¥6.04B
002082SZWBDE
-40.81x--¥5.98B
000813SZDEZHAN HEALTHCARE
-15.19x--¥5.89B
300267SZER-KANG
-16.94x--¥5.88B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.